CGMs, like the Libre systems, can help you manage your glucose levels*†1,‡2—even if you’re not taking insulin.
- Easily see your glucose levels, where they’ve been, and where they’re going.
- Proven to significantly lower A1C*†1 without fingersticks§.
Are FreeStyle Libre systems right for you?
If you want more control over your diabetes, it’s time to start CGM. Ready to discover Libre systems?
CGM = continuous glucose monitor(ing)
How do you currently manage your diabetes?
Oral medication + CGM can help you stay in control.
With the Libre 3 system, Penny can see what food causes her glucose to spike in real time.
“I love that I can see my glucose numbers at anytimeII day or night. My FreeStyle Libre 3 system is always onII and ready to tell me where my numbers are!”
— Penny, manages T2D with oral medication and the FreeStyle Libre 3 system
T2D = type 2 diabetes
Add CGM to your GLP-1 therapy for more insights.
With CGMs like the Libre systems, which provide continuous glucose readings, you can see how your GLP-1 therapy is helping in real time.
- See how food, exercise, and medication impacts your glucose in real time||.
“While GLP-1 medication is something I take to lower and regulate my blood sugar, the FreeStyle Libre 3 system guides me through my diabetic journey more thoughtfully. My FreeStyle Libre 3 system lets me know how well my GLP-1 is working.”
— Dawn manages T2D with GLP-1 therapy and the FreeStyle Libre 3 Plus sensor
GLP-1 = glucagon-like peptide-1; T2D = type 2 diabetes
Pair your compatible pump with our CGM sensors for smarter insulin delivery.
An automated insulin delivery (AID) system provides continuous flow of insulin using data from your CGM sensor.
- Compatible AID systems are designed to precisely adjust your insulin as your glucose goes up and down.
- Accurate3, minute-to-minute glucose readings are sent directly to your compatible AID system.
As a full-time mountain guide, Sarah relies on her pump paired with her Libre 3 system to keep her glucose levels steady.
“My CGM has been a game-changer, and I cannot imagine not having this device ever again.”
— Sarah, manages T1D with an insulin pump and the FreeStyle Libre 3 system
T1D = type 1 diabetes
CGM can help children stay in range, too.
- World’s smallest sensor#4 is easy to apply5—no more painful and inconvenient fingersticks§!
- Easy to share** their glucose readings with other caregivers and healthcare professionals.
- Sleep soundly with customizable alarms†† that alert you when glucose is too low or too high.
Johnny’s parents monitor his glucose levels on their smartphones¶, giving him more freedom to be a kid!
“He is a baseball player, so it takes a huge load of off us being able to watch his glucose readings from our phones¶ without having to interrupt his playing time.”
— Johnny’s mother; Johnny manages T1D with daily insulin injections and the FreeStyle Libre 3 sensor
T1D = type 1 diabetes
See the impact of insulin + CGM.
If you have T1D or T2D, the Libre systems can help you stay on top of your glucose levels. You’ll see your numbers in real time, so you can make insulin adjustments when needed to feel your best.
- Minute-to-minute glucose readings sent directly to your smartphone¶.
- Customizable alarms†† help you know when to take action.
- Save time with no fingersticks§ or logbooks—glucose data is saved on your smartphone¶.
Chelsee lives an active lifestyle and doesn’t let fingerpricking§ get in the way of the activities she enjoys, such as swimming‡‡ and playing soccer.
“The FreeStyle Libre 3 system allows me to go through my day without constantly pricking§ my finger to check my sugars.”
— Chelsee, manages T1D with insulin and the Libre 3 system
T1D = type 1 diabetes; T2D = type 2 diabetes
Libre CGM systems can help you live life with diabetes on your terms.
Everyone’s journey with diabetes is different, and Libre systems put you in control of yours. With Libre CGM systems, you can see how food, exercise, and everyday life impact your glucose—24/7II. And best of all, no fingersticks§ to slow you down!
Libre CGM systems provide real-time glucose readings, so you can decide what’s best for your diabetes management‡6.
Request your prescription, and you’re on your way to better glucose management‡9.
Why wait any longer? Talk to your healthcare provider about Libre CGM systems. This simple discussion guide can help you get the conversation started.
The views expressed should not be used for medical diagnosis or treatment or as a substitute for professional medical advice. Individual symptoms, situations and circumstances may vary.
FreeStyle Libre 3 system is cleared to be used by children 4 years and older with Libre 3 sensor and 2 years and older with Libre 3 Plus sensor.
FreeStyle Libre 2 system is cleared to be used by children 4 years and older with Libre 2 sensor and 2 years and older with Libre 2 Plus sensor.
Medicare and other payor criteria may apply.
* Study was performed with the US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and FreeStyle Libre 2 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
† Retrospective observational study with average baseline A1C 10.1% ± 1.7%.
‡ Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and FreeStyle Libre 2 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
§ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.
II 60-minute warm-up required when starting the sensor.
¶ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
# Among patient-applied sensors.
** The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
†† Alarm notifications will only be received when alarms settings are enabled and turned on and sensor is within 20 feet (FreeStyle Libre 2) or 33 feet (FreeStyle Libre 3) unobstructed of the reading device.
‡‡ Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
♢ Eligible patients will receive one (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 diabetes or Type 2 diabetes or gestational diabetes. Patients ages 18 and older are eligible to sign up and receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor. Patients ages 2–17 are eligible to receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or other federal or state healthcare programs, residents of Massachusetts, or US territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor is provided as a sample and is limited to one sample per eligible person per product identification number. The FreeStyle Libre 2 Plus sensor or FreeStyle Libre 3 Plus sensor cannot be re-sold, traded nor submitted to any third-party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.
References: 1. Wright, Eugene E Jr, et al. "Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy." Diabetes Spectrum 34, no. 2 (2021): 184–189. ds200069. https://doi.org/10.2337/ds20-0069. 2. Aronson, Ronnie, et al. "IMpact of Flash Glucose Monitoring in pEople With Type 2 Diabetes Inadequately Controlled With Non-Insulin Antihyperglycaemic ThErapy (IMMEDIATE): A Randomized Controlled Trial." Diabetes, Obesity and Metabolism 25, no. 4 (2023): 1024–1031. https://doi.org/10.1111/dom.14949. 3. FreeStyle Libre 3 and FreeStyle Libre 2 User Manuals. 4. Data on file. Abbott Diabetes Care, Inc. 5. Alva, Shridhara, et al. "Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System with Improved Sensor Design." Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 6. Fokkert, Marion, et al. "Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4)." BMJ Open Diabetes Research and Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 7. Stress and Diabetes British Diabetes Association. Accessed September 24, 2025. https://www.diabetes.org.uk/living-with-diabetes/emotional-wellbeing/stress. 8. Deepanjali, Vedantam, et al. "Stress-Induced Hyperglycemia: Consequences and Management." Cureus 14, no. 7 (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9360912/. 9. Evans, Mark, Zoë Welsh, and Alexander Seibold. “Reductions in HbA1c With Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-analysis of 75 Real-world Observational Studies.” Diabetes Therapy 13, no. 6 (2022): 1175–1185. https://doi.org/10.1007/s13300-022-01253-9.
ADC-36558 v6.0